# IDELALISIB
> **ANDA216921** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO · Approved 2026-02-17
## Drug
- **FDA Application Number:** ANDA216921
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IDELALISIB
- **Generic name:** Idelalisib
- **Active ingredients:** IDELALISIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NATCO
- **First approval:** 2026-02-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216921)
---
*AI Analytics · CC0 1.0*